Afinitor�, the Novartis trademark for the cancer fighter, everolimus, is used for the treatment of advanced renal cell carcinoma (RCC), inoperable cases of certain pancreatic cancers, and to aid successful acceptance of transplants.� Now, the results of a Phase III study of Afinitor administered to women with advanced breast cancer have been announced, and the words used to describe the drug are "game changer."
Source: http://inventorspot.com/articles/novartis_drug_stops_tumor_growth_lengthens_lives_breast_cancer_p
אין תגובות:
הוסף רשומת תגובה